(Q37945300)

25 August 2017

title

Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. (English)

1 reference

25 August 2017

6

1 reference

25 August 2017

Chiara Porta

1

0 references

author name string

Elena Riboldi

2

1 reference

25 August 2017

Maria Grazia Totaro

3

1 reference

25 August 2017

Laura Strauss

4

1 reference

25 August 2017

Antonio Sica

5

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

3

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1185-1202

1 reference

Elie Metchnikoff: father of natural immunity

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Darwinism and antibody diversity: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Trophic macrophages in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Monocytes: subsets, origins, fates and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The multiple roles of monocyte subsets in steady state and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophages and their products in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage activation by endogenous danger signals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Adipose tissue macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternative activation of macrophages: mechanism and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mechanisms linking pathogens-associated inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The chemokine system in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage polarization to a unique phenotype driven by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Colony-stimulating factors in inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

HPV16 tumor associated macrophages suppress antitumor T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cell-mediated immune responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Antimicrobial mechanisms of phagocytes and bacterial evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Human macrophage host defense against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Foamy macrophages and the progression of the human tuberculosis granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage polarization in bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Toll-like receptors control autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mycobacterium tuberculosis and the intimate discourse of a chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mycobacterium tuberculosis and the macrophage: maintaining a balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chemokines and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Cell biology of HIV-1 infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The macrophage in HIV-1 infection: from activation to deactivation?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternatively activated macrophages in protozoan infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Sabotage and exploitation in macrophages parasitized by intracellular protozoans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternatively activated macrophages in helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chitin, chitinases and chitinase-like proteins in allergic inflammation and tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Protective immune mechanisms in helminth infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chemokines in host-parasite interactions in leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The immunobiology of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The chemokine system: redundancy for robust outputs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

HIV-1 entry inhibitors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

A review of trabectedin (ET-743): a unique mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Biochemical and molecular mechanisms of action of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Bisphosphonates in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Bisphosphonates in preclinical bone oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Antitumor effects and anticancer applications of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeted drug delivery to macrophages in parasitic infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

p50 Nuclear Factor- B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.116

21 January 2018

Identifiers

DOI

10.2217/IMT.11.116

1 reference

25 August 2017

1 reference